Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Protein phosphatase 1D (PPM1D) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the PPM1D transcript, which encodes the WIP1 phosphatase, a member of the PP2C family (Source: UniProt, P49757). This region serves as a primary site for post-transcriptional control, containing binding motifs for several microRNAs such as miR-16 and miR-145 that negatively regulate PPM1D expression (Source: PubMed, PMID: 21150130, 25605116). PPM1D functions as an oncogene by dephosphorylating and inactivating key proteins in the DNA damage response pathway, including p53, Chk1, and p38 MAPK, thereby promoting cell survival and inhibiting apoptosis (Source: PubMed, PMID: 15184876). Overexpression or gain-of-function mutations in PPM1D are frequently observed in breast, ovarian, and lung cancers, often correlating with poor prognosis (Source: PubMed, PMID: 24403010). Therapeutic targeting of the 3'-UTR using antisense oligonucleotides (ASOs) or microRNA mimics aims to reduce PPM1D protein levels, effectively restoring the cell's ability to undergo p53-mediated cell cycle arrest or apoptosis in response to DNA damage (Source: PubMed, PMID: 28655774). This approach is particularly relevant for sensitizing tumor cells to conventional chemotherapy and radiotherapy.
Inhibition of translation and induction of mRNA degradation via RNA interference or antisense binding.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase 1D mRNA 3'-untranslated region (PPM1D mRNA 3'-UTR).